Key points are not available for this paper at this time.
Since the 2004 FDA decision to require a boxed warning on antidepressants regarding the risk of suicidality in children and adolescents, people who feared adverse consequences of that decision have found support for their view in various seriously flawed studies.
Marc B. Stone (Wed,) studied this question.